3(2H)-pyridazinone derivatives: Synthesis, in-silico studies, structure-activity relationship and in-vitro evaluation for acetylcholinesterase enzyme inhibition

ArticleAçık Erişim

Özet

New ten compounds bearing pyridazinone ring (5a–j) were designed and synthesized as acetylcholinesterase inhibitors. The new derivatives were acquired via the reaction of propionohydrazides with substituted/nonsubstituted sulphonylchlorides. The structures of the synthesized compounds were explained using FT-IR, 1H-NMR, 13C-NMR, elemental analysis and HRMS spectra. The inhibition profiles of the synthesized compounds on AChE were researched by comparing their IC50 and KI values. According to the activity studies, all the compounds showed significant inhibitory activity against AChE relative to the reference compound Tacrine. The compound 5g showed the best acetylcholinesterase inhibitory effect with a KI value of 11.61 ± 0.77 nM. For all compounds, the parameters of the interaction points on the receptor side were determined on the ligand basis with the 4D-QSAR model. The synthesized pyridazinone derivatives, 5(a-j), were screened for their acetylcholinesterase inhibitory potential, and the results determined that among the series, compounds 5g, 5f and 5j showed the best inhibition, respectively. For anti-Alzheimer activities, 5g, 5f and 5j compounds were performed in silico studies to understand the binding site, binding energy properties in molecular docking. © 2022

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12650Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÇöl, Ömer Faruk
dc.contributor.authorBozbey, İrem
dc.contributor.authorTürkmenoğlu, Burçin
dc.contributor.authorUysal, Mehtap
dc.date.accessioned2026-10-18T20:27:31.688559250Z
dc.date.available2026-10-18T20:27:31.688559250Z
dc.date.issued2022
dc.description.abstractNew ten compounds bearing pyridazinone ring (5a–j) were designed and synthesized as acetylcholinesterase inhibitors. The new derivatives were acquired via the reaction of propionohydrazides with substituted/nonsubstituted sulphonylchlorides. The structures of the synthesized compounds were explained using FT-IR, 1H-NMR, 13C-NMR, elemental analysis and HRMS spectra. The inhibition profiles of the synthesized compounds on AChE were researched by comparing their IC50 and KI values. According to the activity studies, all the compounds showed significant inhibitory activity against AChE relative to the reference compound Tacrine. The compound 5g showed the best acetylcholinesterase inhibitory effect with a KI value of 11.61 ± 0.77 nM. For all compounds, the parameters of the interaction points on the receptor side were determined on the ligand basis with the 4D-QSAR model. The synthesized pyridazinone derivatives, 5(a-j), were screened for their acetylcholinesterase inhibitory potential, and the results determined that among the series, compounds 5g, 5f and 5j showed the best inhibition, respectively. For anti-Alzheimer activities, 5g, 5f and 5j compounds were performed in silico studies to understand the binding site, binding energy properties in molecular docking. © 2022
dc.description.sponsorshipThe authors would like to thankful Prof. Dr. Yahya Güzel for 4D-QSAR MCET program. The authors are also thankful to Erzincan Binali Yıldırım University, Basic Sciences Application and Research Center (EUTAM) for the Schrödinger Maestro 2021-2 program.
dc.identifier.doi10.1016/j.molstruc.2022.132970
dc.identifier.eissn1872-8014
dc.identifier.issn0022-2860
dc.identifier.scopus2-s2.0-85127990297
dc.identifier.startpage132970
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12650
dc.identifier.volume1261
dc.identifier.wosWOS:000799196800008
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Molecular Structure
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject3(2H)-pyridazinone
dc.subject4D-QSAR
dc.subjectAChE inhibitor
dc.subjectAlzheimer's disease
dc.subjectMolecular docking
dc.subjectBinding energy
dc.subjectComputational chemistry
dc.subjectEnzyme inhibition
dc.subjectMolecular graphics
dc.subjectMolecular modeling
dc.subjectAcetylcholinesterase
dc.subjectAlzheimers disease
dc.subjectIn-silico
dc.subjectPyridazinones
dc.subjectSilico studies
dc.subjectSynthesised
dc.subjectNeurodegenerative diseases
dc.title3(2H)-pyridazinone derivatives: Synthesis, in-silico studies, structure-activity relationship and in-vitro evaluation for acetylcholinesterase enzyme inhibition
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus14
rdl.citation.wos12
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)